An exploratory multimodal pipeline for recurrence prediction in CRC with XELOX therapy
Zhihan Li, Hongqing Ma, Wenbo Niu, Tao Zhang, Zihan Fan, Simeng Jiang · 2026
Read An exploratory multimodal pipeline for recurrence prediction in CRC with XELOX therapy by Zhihan Li, Hongqing Ma, Wenbo Niu, Tao Zhang, Zihan Fan, Simeng Jiang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13518799.txt.
Description
Zhihan Li and five colleagues build an exploratory 2026 model to predict which colorectal cancer patients will relapse after surgery and XELOX chemotherapy. Recurrence strikes many patients within five years, often from hidden residual disease. Better risk sorting could guide follow-up, yet small cohorts make modeling hard.
Records for 86 patients, 17 of whom relapsed, passed through a three-step selection process combining several statistical methods. Four predictors survived: circulating tumor DNA positivity, nerve invasion, high-grade tumor budding, and T stage. Corrected accuracy was modest, with wide uncertainty from the small event count. Li and co-authors stress the model is hypothesis-generating only and needs testing in larger groups.
Catalog record
| CREATOR | Zhihan Li, Hongqing Ma, Wenbo Niu, Tao Zhang, Zihan Fan, Simeng Jiang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38216 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |